Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | Journal of Translational Medicine

Figure 4

From: Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

Figure 4

Fold-changes (ratios to baseline) in mean plasma levels of VEGF and PlGF at different trough levels (x-axis), indicative of a threshold effect. Fold-change values shown are from cycle 1, day 28 over baseline (cycle 1, day 1). *X-axis categories refer to ranges of combined trough drug levels at day 28 of cycle 1 (in ng/mL); **For PIGF, many of the fold-change values are minimum estimates; values below the lower limit of quantification (LLQ) were assigned value equivalent to the LLQ (26.2 pg/mL)

Back to article page